Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Juni 2015

Planlagt Fastgjort Låst Flyttet Genmab
2.2k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • Helge_LarsenPI-redaktørH Offline
    Helge_LarsenPI-redaktørH Offline
    Helge_LarsenPI-redaktør
    wrote on sidst redigeret af
    #981

    Trolle er Trolde. 🙂

    1 Reply Last reply
    0
    • FantomasF Offline
      FantomasF Offline
      Fantomas
      wrote on sidst redigeret af
      #982

      Okay, så er jeg med.

      1 Reply Last reply
      0
      • Legolas23L Offline
        Legolas23L Offline
        Legolas23
        wrote on sidst redigeret af
        #983

        Spændende, hvor langt vi skal ned, før det vender. En GENtest af toppen ifm åbningen plejer at komme i baunched

        1 Reply Last reply
        0
        • FantomasF Offline
          FantomasF Offline
          Fantomas
          wrote on sidst redigeret af
          #984

          Anonymous Broker største køber

          1 Reply Last reply
          0
          • investor1989I Offline
            investor1989I Offline
            investor1989
            wrote on sidst redigeret af
            #985

            Novod har en EPS på 65 i 2020 for Genmab. x30 i P/E og kursen er 1950 dvs. ca. 2000

            1 Reply Last reply
            0
            • DarvinD Offline
              DarvinD Offline
              Darvin
              wrote on sidst redigeret af
              #986

              Hvilket bør være laveste bud - vis der kommer bud i 2015. Også såfremt budgiver kun går efter Dara

              1 Reply Last reply
              0
              • DarvinD Offline
                DarvinD Offline
                Darvin
                wrote on sidst redigeret af
                #987

                hvis

                1 Reply Last reply
                0
                • investor1989I Offline
                  investor1989I Offline
                  investor1989
                  wrote on sidst redigeret af
                  #988

                  Og husk Jan præsenterer hos GS i morgen

                  1 Reply Last reply
                  0
                  • I Offline
                    I Offline
                    ienk1
                    wrote on sidst redigeret af
                    #989

                    hvad har GS som kursmål

                    1 Reply Last reply
                    0
                    • investor1989I Offline
                      investor1989I Offline
                      investor1989
                      wrote on sidst redigeret af
                      #990

                      pas

                      1 Reply Last reply
                      0
                      • I Offline
                        I Offline
                        ienk1
                        wrote on sidst redigeret af
                        #991

                        Jeg mener at kunne huske , at de lå meget lavt

                        1 Reply Last reply
                        0
                        • FantomasF Offline
                          FantomasF Offline
                          Fantomas
                          wrote on sidst redigeret af
                          #992

                          http://investor.borsen.dk/artikel/1/298223/danske_loefter_genmab-kursmaal_markant.html kan ikke lige huske om de har opdateret kursmålet siden.

                          1 Reply Last reply
                          0
                          • G Offline
                            G Offline
                            Goose3
                            wrote on sidst redigeret af
                            #993

                            FF hæver til 715 (fra 620)

                            1 Reply Last reply
                            0
                            • investor1989I Offline
                              investor1989I Offline
                              investor1989
                              wrote on sidst redigeret af
                              #994

                              Han er ved at blive lidt sød ham Frank 😄

                              1 Reply Last reply
                              0
                              • G Offline
                                G Offline
                                Goose3
                                wrote on sidst redigeret af
                                #995

                                Jeps men altid farligt med FF. Kan huske at jeg undlod af sælge Neuroseach da han blev ved med at sige at data var gode nok til en ansøgning. Det var de så ikke!

                                1 Reply Last reply
                                0
                                • G Offline
                                  G Offline
                                  Goose3
                                  wrote on sidst redigeret af
                                  #996

                                  Så jeg lytter ikke til FF mere selvom alle kan tage fejl!

                                  1 Reply Last reply
                                  0
                                  • 1 Offline
                                    1 Offline
                                    120281
                                    wrote on sidst redigeret af
                                    #997

                                    @i89: Kan du sende mig en PB kan ikke lige finde det. Ang. aktiebrev.

                                    1 Reply Last reply
                                    0
                                    • DarvinD Offline
                                      DarvinD Offline
                                      Darvin
                                      wrote on sidst redigeret af
                                      #998

                                      Resumeet fra ASCO har jo været fremme siden 30 maj - men havde ikke selv set denne tilføjelse ( Medscape), det har i måske, men her er den: "A response lasting 7.4 months in this population is quite remarkable," commented Suzanne Lentzsch, MD, PhD, director of the Multiple Myeloma and Amyloidosis Service at New York–Presbyterian Hospital/Columbia University Medical Center, in New York City. "This shows its potency in a heavily pretreated population."

                                      "This is a study of 106 patients, which is

                                      1 Reply Last reply
                                      0
                                      • DarvinD Offline
                                        DarvinD Offline
                                        Darvin
                                        wrote on sidst redigeret af
                                        #999

                                        "This is a study of 106 patients, which is fairly large and straightforward and gives us insight into the single-drug activity with this agent," said Dr Lentzsch, who was approached by Medscape Medical News for independent commentary.

                                        However, Dr Lentzsch believes that daratumumab will probably not be used as a single agent but as part of combination therapy. Daratumumab is currently being studied in several ongoing phase 3 trials that are exploring daratumumab in combination with various exist

                                        1 Reply Last reply
                                        0
                                        • DarvinD Offline
                                          DarvinD Offline
                                          Darvin
                                          wrote on sidst redigeret af
                                          #1000

                                          However, Dr Lentzsch believes that daratumumab will probably not be used as a single agent but as part of combination therapy. Daratumumab is currently being studied in several ongoing phase 3 trials that are exploring daratumumab in combination with various existing regimens in different stages of the disease.

                                          "The next step is to establish efficacy in combination with other agents and to bring it to frontline therapy," she said.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger